Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

BACKGROUND/AIMS: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 infection. METHODS: We...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Mol Hepatol
Glavni autori: Kim, Young Min, Kim, Suk Bae, Song, Il Han, Lee, Sae Hwan, Kim, Hong Soo, Lee, Tae Hee, Kang, Young Woo, Kim, Seok Hyun, Lee, Byung Seok, Chae, Hee Bok, Song, Myeong Jun, Jang, Ji Woong, Ko, Soon Young, Lee, Jae Dong
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association for the Study of the Liver 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166109/
https://ncbi.nlm.nih.gov/pubmed/29865774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2017.0070
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items